FDA Drug Application (203312) for RYTARY by IMPAX LABS INC

Back to FDA Applications sponsored by IMPAX LABS INC

Application Number203312
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage23.75MG;95MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRYTARY
Active IngredientCARBIDOPA; LEVODOPA

Active IngredientCount
List of drugs with Active Ingredient CARBIDOPA16
List of drugs with Active Ingredient LEVODOPA17


Back to FDA Applications sponsored by IMPAX LABS INC